Diagnostic accuracy of mpMRI and fusion-guided targeted biopsy evaluated by transperineal template saturation prostate biopsy for the detection and characterization of prostate cancer
The Journal of Urology Feb 24, 2018
Mortezavi A, et al. - The diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) and mpMRI / transrectal ultrasound (TRUS) fusion-guided targeted biopsy (FTB) against transperineal template saturation prostate biopsy (TTSPB) was evaluated by the researchers for the detection of prostate cancer (PCa). Due to a substantial number of false-negative cases with clinically significant PCa (csPCa), mpMRI alone ought not to be used as a triage test. In the diagnostic pathway of PCa, systematic biopsy outperformed fusion-guided targeted biopsy and hence remained crucial.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries